Ultrasound-mediated targeted microbubbles: a new vehicle for cancer therapy
Ultrasound-mediated targeted microbubbles: a new vehicle for cancer therapy
Junxiao YE1, Huining HE1,4,5(), Junbo GONG1, Weibing DONG1, Yongzhuo HUANG2,3, Jianxin WANG3, Guanyi CHEN4, Victor C YANG5,6()
1. School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China; 2. Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; 3. Department of Pharmaceutics, School of Pharmacy, Fudan University; Key Laboratory of Smart Drug Delivery, Ministry of Education & PLA, Shanghai 201203, China; 4. School of Environmental Science and Engineering, State Key Laboratory of Engines, Tianjin University, Tianjin 300072, China; 5. Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China; 6. Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109-1065, USA
With the hope of overcoming the serious side effects, great endeavor has been made in tumor-targeted chemotherapy, and various drug delivery modalities and drug carriers have been made to decrease systemic toxicity caused by chemotherapeutic agents. Scientists from home and abroad focus on the research of targeted microbubbles contrast agent, and the use of the targeted ultrasound microbubble contrast agent can carry gene drugs and so on to the target tissue, as well as mediated tumor cell apoptosis and tumor microvascular thrombosis block, etc., thus plays the role of targeted therapy. Recent studies have elucidated the mechanisms of drug release and absorption, however, much work remains to be done in order to develop a successful and optimal system. In this review, we summarized the continuing efforts in understanding the usage of the ultrasound triggered target microbubbles in cancer therapy, from release mechanism to preparation methods. The latest applications of ultrasound-triggered targeted microbubbles in cancer therapy, especially in gene therapy and antiangiogenic cancer therapy were discussed. Moreover, we concluded that as a new technology, ultrasound–triggered targeted microbubbles used as drug carriers and imaging agents are still energetic and are very likely to be translated into clinic in the near future.
Corresponding Author(s):
HE Huining,Email:hnhe@tju.edu.cn; YANG Victor C,Email:vcyang@umich.edu
引用本文:
. Ultrasound-mediated targeted microbubbles: a new vehicle for cancer therapy[J]. Frontiers of Chemical Science and Engineering, 2013, 7(1): 20-28.
Junxiao YE, Huining HE, Junbo GONG, Weibing DONG, Yongzhuo HUANG, Jianxin WANG, Guanyi CHEN, Victor C YANG. Ultrasound-mediated targeted microbubbles: a new vehicle for cancer therapy. Front Chem Sci Eng, 2013, 7(1): 20-28.
Rapoport N. Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery. Progress in Polymer Science , 2007, 32(8–9): 962–990 doi: 10.1016/j.progpolymsci.2007.05.009
2
Deckers R, Moonen C T W. Ultrasound triggered, image guided, local drug delivery. Journal of Controlled Release , 2010, 148(1): 25–33 doi: 10.1016/j.jconrel.2010.07.117
3
Heath C H, Sorace A, Knowles J, Rosenthal E, Hoyt K. Microbubble therapy enhances anti-tumor properties of cisplatin and cetuximab in vitro and in vivo. Otolaryngology- Head and Neck Surgery , 2012, 146(6): 938–945 doi: 10.1177/0194599812436648
4
Bekeredjian R, Kroll R D, Fein E, Tinkov S, Coester C, Winter G, Katus H A, Kulaksiz H. Ultrasound targeted microbubble destruction increases capillary permeability in hepatomas. Ultrasound in Medicine & Biology , 2007, 33(10): 1592–1598 doi: 10.1016/j.ultrasmedbio.2007.05.003
5
Carson A R, McTiernan C F, Lavery L, Grata M, Leng X, Wang J, Chen X, Villanueva F S. Ultrasound-targeted microbubble destruction to deliver siRNA cancer therapy. Cancer Research , 2012, 72(23): 6191–6199 doi: 10.1158/0008-5472.CAN-11-4079
6
Chang S, Guo J, Sun J, Zhu S, Yan Y, Zhu Y, Li M, Wang Z, Xu R X. Targeted microbubbles for ultrasound mediated gene transfection and apoptosis induction in ovarian cancer cells. Ultrasonics Sonochemistry , 2013, 20(1): 171–179 doi: 10.1016/j.ultsonch.2012.06.015
7
Gao Z, Kennedy A M, Christensen D A, Rapoport N Y. Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics , 2008, 48(4): 260–270 doi: 10.1016/j.ultras.2007.11.002
8
Korpanty G, Chen S, Shohet R V, Ding J, Yang B, Frenkel P A, Grayburn P A. Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles. Gene Therapy , 2005, 12(17): 1305–1312 doi: 10.1038/sj.gt.3302532
9
Park K. Microbubble ultrasound-guided targeted delivery to tumors. Journal of Controlled Release , 2012, 157(2): 167 doi: 10.1016/j.jconrel.2011.12.028
10
Korpanty G, Grayburn P A, Shohet R V, Brekken R A. Targeting vascular endothelium with avidin microbubbles. Ultrasound in Medicine & Biology , 2005, 31(9): 1279–1283 doi: 10.1016/j.ultrasmedbio.2005.06.001
11
Villanueva F S. Ultrasound mediated destruction of DNA-loaded microbubbles for enhancement of cell-based therapies. JACC: Cardiovascular Imaging , 2009, 2(7): 880–882 doi: 10.1016/j.jcmg.2009.05.006
12
Gao Z G, Fain H D, Rapoport N. Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. Journal of Controlled Release , 2005, 102(1): 203–222 doi: 10.1016/j.jconrel.2004.09.021
13
Rapoport N, Gao Z, Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. Journal of the National Cancer Institute , 2007, 99(14): 1095–1106 doi: 10.1093/jnci/djm043
14
Gao Z, Fain H D, Rapoport N. Ultrasound-enhanced tumor targeting of polymeric micellar drug carriers. Molecular Pharmaceutics , 2004, 1(4): 317–330 doi: 10.1021/mp049958h
15
Dijkmans P, Juffermans L, Musters R, Vanwamel A, Tencate F, Vangilst W, Visser C, Dejong N, Kamp O. Microbubbles and ultrasound: from diagnosis to therapy. European Journal of Echocardiography , 2004, 5(4): 245–256 doi: 10.1016/j.euje.2004.02.001
16
Stride E, Saffari N. On the destruction of microbubble ultrasound contrast agents. Ultrasound in Medicine & Biology , 2003, 29(4): 563–573 doi: 10.1016/S0301-5629(02)00787-1
17
Basta G, Venneri L, Lazzerini G, Pasanisi E, Pianelli M, Vesentini N, Del Turco S, Kusmic C, Picano E. In vitro modulation of intracellular oxidative stress of endothelial cells by diagnostic cardiac ultrasound. Cardiovascular Research , 2003, 58(1): 156–161 doi: 10.1016/S0008-6363(02)00665-X
18
Wu J. Temperature rise generated by ultrasound in the presence of contrast agent. Ultrasound in Medicine & Biology , 1998, 24(2): 267–274 doi: 10.1016/S0301-5629(97)00246-9
19
Unger E C, Hersh E, Vannan M, Matsunaga T O, McCreery T. Local drug and gene delivery through microbubbles. Progress in Cardiovascular Diseases , 2001, 44(1): 45–54 doi: 10.1053/pcad.2001.26443
20
Liu Y, Miyoshi H, Nakamura M. Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery. Journal of Controlled Release , 2006, 114(1): 89–99 doi: 10.1016/j.jconrel.2006.05.018
21
Klibanov A L. Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Advanced Drug Delivery Reviews , 1999, 37(1-3): 139–157 doi: 10.1016/S0169-409X(98)00104-5
22
Fokong S, Theek B, Wu Z, Koczera P, Appold L, Jorge S, Resch-Genger U, van Zandvoort M, Storm G, Kiessling F, Lammers T. Image-guided, targeted and triggered drug delivery to tumors using polymer-based microbubbles. Journal of Controlled Release , 2012, 163(1): 75–81 doi: 10.1016/j.jconrel.2012.05.007
23
Zhao Y Z, Lu C T, Mei X G. Optimization of the preparation of sonogenic phospholipids-based microbubbles by using central composite experimental design and response surface methodology. Acta pharmaceutica Sinica , 2008, 43(8): 862–867 (in Chinese)
24
Wang D S, Panje C, Pysz M A, Paulmurugan R, Rosenberg J, Gambhir S S, Schneider M, Willmann J K. Cationic versus neutral microbubbles for ultrasound-mediated gene delivery in cancer. Radiology , 2012, 264(3): 721–732 doi: 10.1148/radiol.12112368
25
Higuchi Y, Kawakami S, Hashida M. Strategies for in vivo delivery of siRNAs: recent progress. BioDrugs , 2010, 24(3): 195–205 doi: 10.2165/11534450-000000000-00000
26
Carson A R, McTiernan C F, Lavery L, Hodnick A, Grata M, Leng X, Wang J, Chen X, Modzelewski R A, Villanueva F S. Gene therapy of carcinoma using ultrasound-targeted microbubble destruction. Ultrasound in Medicine & Biology , 2011, 37(3): 393–402 doi: 10.1016/j.ultrasmedbio.2010.11.011
27
Feril L B Jr. Ultrasound-mediated gene transfection. Methods in Molecular Biology (Clifton, N.J.) , 2009, 542: 179–194 doi: 10.1007/978-1-59745-561-9_10
29
Guo D P, Li X Y, Sun P, Tang Y B, Chen X Y, Chen Q, Fan L M, Zang B, Shao L Z, Li X R. Ultrasound-targeted microbubble destruction improves the low density lipoprotein receptor gene expression in HepG2 cells. Biochemical and Biophysical Research Communications , 2006, 343(2): 470–474 doi: 10.1016/j.bbrc.2006.02.179
30
Unger E C, Matsunaga T O, McCreery T, Schumann P, Sweitzer R, Quigley R. Therapeutic applications of microbubbles. European Journal of Radiology , 2002, 42(2): 160–168 doi: 10.1016/S0720-048X(01)00455-7
31
Liu Y, Yang H, Sakanishi A. Ultrasound: mechanical gene transfer into plant cells by sonoporation. Biotechnology Advances , 2006, 24(1): 1–16 doi: 10.1016/j.biotechadv.2005.04.002
32
Sirsi S R, Hernandez S L, Zielinski L, Blomback H, Koubaa A, Synder M, Homma S, Kandel J J, Yamashiro D J, Borden M A. Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors. Journal of Controlled Release , 2012, 157(2): 224–234 doi: 10.1016/j.jconrel.2011.09.071
33
Li X H, Zhou P, Wang L H, Tian S M, Qian Y, Chen L R, Zhang P. The targeted gene (KDRP-CD/TK) therapy of breast cancer mediated by SonoVue and ultrasound irradiation in vitro. Ultrasonics , 2012, 52(1): 186–191 doi: 10.1016/j.ultras.2011.08.002
34
Li Y S, Davidson E, Reid C N, McHale A P. Optimising ultrasound-mediated gene transfer (sonoporation) in vitro and prolonged expression of a transgene in vivo: potential applications for gene therapy of cancer. Cancer Letters , 2009, 273(1): 62–69 doi: 10.1016/j.canlet.2008.07.030
35
Luo J, Zhou X, Diao L, Wang Z. Experimental research on wild-type p53 plasmid transfected into retinoblastoma cells and tissues using an ultrasound microbubble intensifier. Journal of International Medical Research , 2010, 38(3): 1005–1015
36
Tang Q, He X, Liao H, He L, Wang Y, Zhou D, Ye S, Chen Q. Ultrasound microbubble contrast agent-mediated suicide gene transfection in the treatment of hepatic cancer. Oncology Letters , 2012, 4(5): 970–972
37
Wang J F, Wang J B, Chen H, Zhang C M, Liu L, Pan S H, Wu C J. Ultrasound-mediated microbubble destruction enhances gene transfection in pancreatic cancer cells. Advances in Therapy , 2008, 25(5): 412–421 doi: 10.1007/s12325-008-0051-9
38
Watanabe A, Otake R, Nozaki T, Morii A, Ogawa R, Fujimoto S, Nakamura S, Fuse H, Kondo T. Effects of microbubbles on ultrasound-mediated gene transfer in human prostate cancer PC3 cells: comparison among Levovist, YM454, and MRX-815H. Cancer Letters , 2008, 265(1): 107–112 doi: 10.1016/j.canlet.2008.02.004
39
Chen Z Y, Liang K, Qiu R X. Targeted gene delivery in tumor xenografts by the combination of ultrasound-targeted microbubble destruction and polyethylenimine to inhibit survivin gene expression and induce apoptosis. Journal of Experimental & Clinical Cancer Research , 2010, 29(1): 152–160 doi: 10.1186/1756-9966-29-152
40
Rahim A A, Taylor S L, Bush N L, ter Haar G R, Bamber J C, Porter C D. Spatial and acoustic pressure dependence of microbubble-mediated gene delivery targeted using focused ultrasound. Journal of Gene Medicine , 2006, 8(11): 1347–1357 doi: 10.1002/jgm.962
41
Rahim A, Taylor S L, Bush N L, ter Haar G R, Bamber J C, Porter C D. Physical parameters affecting ultrasound/microbubble-mediated gene delivery efficiency in vitro. Ultrasound in Medicine & Biology , 2006, 32(8): 1269–1279 doi: 10.1016/j.ultrasmedbio.2006.04.014
42
Bazan-Peregrino M, Arvanitis C D, Rifai B, Seymour L W, Coussios C C. Ultrasound-induced cavitation enhances the delivery and therapeutic efficacy of an oncolytic virus in an in vitro model. Journal of Controlled Release , 2012, 157(2): 235–242 doi: 10.1016/j.jconrel.2011.09.086
43
O Boussif F L h, M A Zanta, M D Mergny, D Scherman, B Demeneix, J PBehr. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proceedings of the National Academy of Sciences of the United States of America , 1995, 92(16): 7297–7301
44
Cochran M C, Eisenbrey J, Ouma R O, Soulen M, Wheatley M A. Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery. International Journal of Pharmaceutics , 2011, 414(1-2): 161–170 doi: 10.1016/j.ijpharm.2011.05.030
45
Hobbs S K, Monsky W L, Yuan F, Roberts W G, Griffith L, Torchilin V P, Jain R K. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proceedings of the National Academy of Sciences of the United States of America , 1998, 95(8): 4607–4612 doi: 10.1073/pnas.95.8.4607
46
Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. Journal of Controlled Release , 2000, 65(1-2): 271–284 doi: 10.1016/S0168-3659(99)00248-5
47
Ferrara K W, Borden M A, Zhang H. Lipid-shelled vehicles: engineering for ultrasound molecular imaging and drug delivery. Accounts of Chemical Research , 2009, 42(7): 881–892 doi: 10.1021/ar8002442
48
Eisenbrey J R, Burstein O M, Kambhampati R, Forsberg F, Liu J B, Wheatley M A. Development and optimization of a doxorubicin loaded poly(lactic acid) contrast agent for ultrasound directed drug delivery. Journal of Controlled Release , 2010, 143(1): 38–44 doi: 10.1016/j.jconrel.2009.12.021
49
Mohan P, Rapoport N. Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking. Molecular Pharmaceutics , 2010, 7(6): 1959–1973 doi: 10.1021/mp100269f
50
Eisenbrey J R, Soulen M C, Wheatley M A. Delivery of encapsulated Doxorubicin by ultrasound-mediated size reduction of drug-loaded polymer contrast agents. IEEE Transactions on Bio-Medical Engineering , 2010, 57(1): 24–28 doi: 10.1109/TBME.2009.2030497
51
Lum A F, Borden M A, Dayton P A, Kruse D E, Simon S I, Ferrara K W. Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. Journal of Controlled Release , 2006, 111(1-2): 128–134 doi: 10.1016/j.jconrel.2005.11.006
53
Guibal A, Taillade L, Mule S, Comperat E, Badachi Y, Golmard J L, Le Guillou-Buffello D, Rixe O, Bridal S L, Lucidarme O. Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: effect of discontinuing anti-VEGF therapy. Radiology , 2010, 254(2): 420–429 doi: 10.1148/radiol.09090728
54
Leong-Poi H, Christiansen J, Klibanov A L, Kaul S, Lindner J R. Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins. Circulation , 2003, 107(3): 455–460 doi: 10.1161/01.CIR.0000044916.05919.8B
55
Hu G Q, Yang L, Xiao Y B, Xie J J, Wu J F, Cai J J, Liu J, Liao W J, Bin J P. Evaluation of tumor angiogenesis using microbubbles conjugated with RGD peptides and contrast enhanced ultrasound. Zhonghua Zhong Liu Za Zhi , 2010, 32(9): 655–658 (in Chinese)
56
Warram J M, Sorace A G, Saini R, Borovjagin A V, Hoyt K, Zinn K R. Systemic delivery of a breast cancer-detecting adenovirus using targeted microbubbles. Cancer Gene Therapy , 2012, 19(8): 545–552 doi: 10.1038/cgt.2012.29
57
Warram J M, Sorace A G, Saini R, Umphrey H R, Zinn K R, Hoyt K. A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature. Journal of Ultrasound in Medicine , 2011, 30(7): 921–931
58
Patan S. Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. Journal of Neuro-Oncology , 2000, 50(1-2): 1–15 doi: 10.1023/A:1006493130855
59
Patan S. Vasculogenesis and angiogenesis. Cancer Treatment and Research , 2004, 117: 3–32 doi: 10.1007/978-1-4419-8871-3_1
60
Price R J, Skyba D M, Kaul S, Skalak T C. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation , 1998, 98(13): 1264–1267 doi: 10.1161/01.CIR.98.13.1264
61
Skyba D M, Price R J, Linka A Z, Skalak T C, Kaul S. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation , 1998, 98(4): 290–293 doi: 10.1161/01.CIR.98.4.290
62
Tammela T, Zarkada G, Wallgard E, Murtomaki A, Suchting S, Wirzenius M, Waltari M, Hellstrom M, Schomber T, Peltonen R, Freitas C, Duarte A, Isoniemi H, Laakkonen P, Christofori G, Yl?-Herttuala S, Shibuya M, Pytowski B, Eichmann A, Betsholtz C, Alitalo K. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature , 2008, 454(7204): 656–660 doi: 10.1038/nature07083
63
Pysz M A, Foygel K, Rosenberg J, Gambhir S S, Schneider M, Willmann J K. Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). Radiology , 2010, 256(2): 519–527 doi: 10.1148/radiol.10091858
64
Palmowski M, Huppert J, Ladewig G, Hauff P, Reinhardt M, Mueller M M, Woenne E C, Jenne J W, Maurer M, Kauffmann G, Semmler W, Kiessling F. Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects. Molecular Cancer Therapeutics , 2008, 7(1): 101–109 doi: 10.1158/1535-7163.MCT-07-0409
65
Anderson C R, Hu X, Zhang H, Tlaxca J, Decleves A E, Houghtaling R, Sharma K, Lawrence M, Ferrara K W, Rychak J J. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. Investigative Radiology , 2011, 46(4): 215–224 doi: 10.1097/RLI.0b013e3182034fed
67
Fan C H, Ting C Y, Liu H L, Huang C Y, Hsieh H Y, Yen T C, Wei K C, Yeh C K. Antiangiogenic-targeting drug-loaded microbubbles combined with focused ultrasound for glioma treatment. Biomaterials , 2013, 34(8): 2142–2155 doi: 10.1016/j.biomaterials.2012.11.048
68
Williams R, Hudson J M, Lloyd B A, Sureshkumar A R, Lueck G, Milot L, Atri M, Bjarnason G A, Burns P N. Dynamic microbubble contrast-enhanced US to measure tumor response to targeted therapy: a proposed clinical protocol with results from renal cell carcinoma patients receiving antiangiogenic therapy. Radiology , 2011, 260(2): 581–590 doi: 10.1148/radiol.11101893
69
Sirsi S R, Flexman M L, Vlachos F, Huang J, Hernandez S L, Kim H K, Johung T B, Gander J W, Reichstein A R, Lampl B, Wang A, Hielscher A H, Kandel J J, Yamashiro D J, Borden M A. Contrast ultrasound imaging for identification of early responder tumor models to anti-angiogenic therapy. Ultrasound in Medicine & Biology , 2012, 38(6): 1019–1029 doi: 10.1016/j.ultrasmedbio.2012.01.014
70
Rix A, Lederle W, Siepmann M, Fokong S, Behrendt F F, Bzyl J, Grouls C, Kiessling F, Palmowski M. Evaluation of high frequency ultrasound methods and contrast agents for characterising tumor response to anti-angiogenic treatment. European Journal of Radiology , 2012, 81(10): 2710–2716 doi: 10.1016/j.ejrad.2011.10.004